Simvastatin News
Pharmaust generic drug wins TGA approval
Nedlands-based pharmaceutical company PharmAust Ltd has secured approval from Australia's Therapeutic Goods Administration for its generic version of the cholesterol lowering drug Simavastatin. The full text of a company...
Prescriptions for Cholesterol Drugs Rise with New Generics
Prescriptions for the cholesterol-lowering medicines known as statins rose by an average of 500,000 a month between October 2005 and December 2006, according to a new analysis by Consumers Union and Consumer Reports Best Buy...
Schering-Plough sees growth of cholesterol drugs
Schering-Plough Corp. said it expects combined sales of its cholesterol fighters Zetia and Vytorin to grow in 2007, despite the recent launch of additional generic forms of Merck & Co. Inc.'s rival Zocor drug.
Price for Widely Used Cholesterol Drug Drops 90 Percent
HealthPartners estimates that its drug costs will decrease by more than $10 million annually after the expiration of a court order that protected the price of simvastatin, a generic version of the cholesterol drug ZocorŪ. The...
Scientist raises fears over statins and Parkinson's
Scientists are to investigate why people with low cholesterol levels appear to be more likely to develop Parkinson's disease.